We are live on ! Find out more
ANGO icon

AngioDynamics

173 hedge funds and large institutions have $692M invested in AngioDynamics in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 54 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

40,300% more call options, than puts

Call options by funds: $404K | Put options by funds: $1K

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

37% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 54

4% more funds holding

Funds holding: 167173 (+6)

0.61% more ownership

Funds ownership: 99.72%100.33% (+0.61%)

5% less capital invested

Capital invested by funds: $731M → $692M (-$39.1M)

Holders
173
Holders Change
+6
Holders Change %
+3.59%
% of All Funds
3.79%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
74
Reduced
54
Closed
11
Calls
$404K
Puts
$1K
Net Calls
+$403K
Net Calls Change
-$51K
Name Holding Trade Value Shares
Change
Change in
Stake
USAA
176
United Services Automobile Association
Texas
-$420K -21,317 Closed
FIM
177
Freedom Investment Management
Connecticut
-$318K -16,136 Closed
ARTA
178
A.R.T. Advisors
New York
-$226K -11,500 Closed
SG Americas Securities
179
SG Americas Securities
New York
-$146K -7,403 Closed
ADEF
180
Adams Diversified Equity Fund
Maryland
-$120K -6,100 Closed
CAW
181
Cornerstone Advisors (Washington)
Washington
-$1K -64 Closed

ANGO Hedge Fund Activity: Q3 2019 in Review

173 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2019, worth a combined $692M — down 5.4% from $731M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ANGO positions and 11 closed out — a net gain of 6 holders — while 74 added to existing stakes and 54 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $5.1M. The largest seller was Millennium Management, cutting an estimated $5.75M.

  • 173 institutional investors held AngioDynamics (ANGO) as of Q3 2019, up from 167 in Q2 2019.
  • Funds reported $692M of AngioDynamics stock for Q3 2019, down 5.4% quarter-over-quarter.
  • 17 funds opened new AngioDynamics positions in Q3 2019 and 11 closed out, a net change of +6 holders.
  • The largest AngioDynamics buyer in Q3 2019 was Victory Capital Management, an estimated $5.1M added.
  • The largest AngioDynamics seller in Q3 2019 was Millennium Management, an estimated $5.75M sold.

Based on aggregated 13F filings for Q3 2019.